Difficulty: Medium
Average Score: 64%
Practice
Tick the positive inotropic drug of non-glycoside structure:
Correct answer
C
Rationale
In the context of Advanced Pharmacology Across the Lifespan, understanding the classification of positive inotropic drugs is crucial. The correct answer is C) Dobutamine. Dobutamine is a synthetic catecholamine with direct beta-1 adrenergic agonist activity, leading to increased myocardial contractility without significant chronotropic effects.
A) Digitoxin and B) Digoxin are cardiac glycosides derived from the foxglove plant. They exert their positive inotropic effects by inhibiting the Na+/K+ ATPase pump, leading to an increase in intracellular calcium levels.
D) Strophanthin is another cardiac glycoside obtained from the seeds of Strophanthus plant and acts similarly to Digitoxin and Digoxin.
Educationally, understanding the nuances between different classes of inotropic agents is vital for prescribing appropriate treatments for patients with various cardiac conditions. Dobutamine, as a non-glycoside positive inotropic agent, is often used in acute heart failure, cardiogenic shock, and certain types of heart failure where glycosides may not be suitable. This knowledge is essential for healthcare professionals to ensure safe and effective pharmacological interventions in diverse patient populations.
A) Digitoxin and B) Digoxin are cardiac glycosides derived from the foxglove plant. They exert their positive inotropic effects by inhibiting the Na+/K+ ATPase pump, leading to an increase in intracellular calcium levels.
D) Strophanthin is another cardiac glycoside obtained from the seeds of Strophanthus plant and acts similarly to Digitoxin and Digoxin.
Educationally, understanding the nuances between different classes of inotropic agents is vital for prescribing appropriate treatments for patients with various cardiac conditions. Dobutamine, as a non-glycoside positive inotropic agent, is often used in acute heart failure, cardiogenic shock, and certain types of heart failure where glycosides may not be suitable. This knowledge is essential for healthcare professionals to ensure safe and effective pharmacological interventions in diverse patient populations.